Combination progestin/oestrogen potency similarly showed a significant trend of increasing breast cancer risk with increasing potency ( P trend <0.01); recent use of low progestin/low oestrogen potency pills was associated with a RR of 1.79, low progestin/high oestrogen potency with a RR of 2.53, and high progestin/low oestrogen potency with a RR of 8.07.
← all excerpts
Hormonal content and potency of oral contraceptives and breast cancer risk among young women.
1
—
—